Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The medical device sector is considered as one of the sunrise sectors in the country
Subscribe To Our Newsletter & Stay Updated
